43738 Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Notices

submit a brief statement of the general

nature of the evidence or arguments

they wish to present, the names and

addresses of proposed participants, and

an indication of the approximate time

requested to make their presentation.

Closed Committee Deliberations: On

September 30, 1997, from 8:30 a.m. to

9:30 a.m., the meeting will be closed to

permit discussion where disclosure

would constitute a clearly unwarranted

invasion of personal privacy (5 U.S.C.

552b(c)(6)). The board will discuss

nominations for, and select recipients

of, the 1997 FDA Scientific

Achievement Awards. Such discussion

in a public meeting would disclose

information of a personal nature and

would constitute a clearly unwarranted

invasion of personal privacy.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: August 7, 1997.

William K. Hubbard,

Acting Deputy Commissioner for Policy.

[FR Doc. 97–21722 Filed 8–14–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–437]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding the burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

1. Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: Psychiatric Unit

Criteria Work Sheet, Rehabilitation Unit

Criteria Work Sheet, Rehabilitation

Hospital Criteria Work Sheet and

Supporting Regulations 42 CFR 412.20–

412.32; Form No.: HCFA–437; Use:

Rehabilitation hospitals and Psychiatric

hospital units that are excluded from

the Medicare Prospective Payment

System (PPS) must complete the criteria

work sheets to verify and reverify that

they comply and remain in compliance

with the exclusion criteria for the

Medicare prospective payment system.

These forms capture information that

will allow Medicare to reimburse these

facilities on the basis of nationallydetermined average standardized

amounts, i.e., a prospective payment

type system. Frequency: Annually;

Affected Public: Business or other forprofit, Not-for-profit institutions and

State, Local or Tribal Government;

Number of Respondents: 2,555; Total

Annual Responses: 2,555; Total Annual

Hours: 639.

2.Type of Information Collection

Request: Revision of a currently

approved collection; Title of

Information Collection: Reconciliation

of State Invoice and Prior Quarter

Adjustment Statement; Form No.:

HCFA–304A; Use: In response to a need

for improved data exchange between

drug labelers and States, HCFA, in

conjunction with outside consultants,

developed the Reconciliation of State

Invoice (ROSI), form HCFA–304, and

the Prior Quarter Adjustment Statement

(PQAS), form HCFA–304A. The ROSI is

to be used by drug labelers when

responding to State invoices of current

quarter utilization data only, and

functions as a reconciliation report to

assure accurate drug rebate payments.

The PQAS is used by drug labelers to

report only on prior quarter actions/

payments. Prior quarter activity

includes changes to utilization data

submitted by States, revisions to

previously disputed units, and prior

period adjustments (URA changes). Both

forms assist in reducing disputes by

standardizing data exchange and

improving communication between

drug labelers and States. Frequency:

Quarterly; Affected Public: Business or

other for-profit; Number of

Respondents: 365; Total Annual

Responses: 1,460; Total Annual Hours:

132,120.

To obtain copies of the supporting

statement for the proposed paperwork

collections referenced above, or to

obtain the supporting statement and any

related forms, E-mail your request,

including your address and phone

number, to Paperwork@hcfa.gov, or call

the Reports Clearance Office on (410)

786–1326. Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Information Technology Investment

Management Group, Division of HCFA

Enterprise Standards, Attention: John

Rudolph, Room C2–26–17, 7500

Security Boulevard, Baltimore,

Maryland 21244–1850.

Dated: August 5, 1997.

John P. Burke III,

HCFA Reports Clearance Officer, Division of

HCFA Enterprise Standards, Health Care

Financing Administration.

[FR Doc. 97–21654 Filed 8–14–97; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–2384]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

AGENCY: Health Care Financing

Administration.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Collection

Request: Reinstatement, without change,

of a previously approved collection for

which approval has expired; Title of

Information Collection: Third Party

Premium Billing Request and

Supporting Regulations in 42 CFR

408.6; Form No.: HCFA–2384 (OMB

0938–0041); Use: The Third Party

Premium Billing Request is used as an

authorization form to designate that a

family member or other interested party
Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Notices 43739

receive the Medicare premium bill and

pay it on behalf of a Medicare

beneficiary. Frequency: On occasion;

Affected Public: Individuals or

Households; Number of Respondents:

15,000; Total Annual Responses:

15,000; Total Annual Hours: 6,250.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, E-mail your request,

including your address and phone

number, to Paperwork@hcfa.gov, or call

the Reports Clearance Office on (410)

786–1326. Written comments and

recommendations for the proposed

information collections must be mailed

within 30 days of this notice directly to

the OMB desk officer: OMB Human

Resources and Housing Branch,

Attention: Allison Eydt, New Executive

Office Building, Room 10235,

Washington, D.C. 20503.

Dated: August 5, 1997.

John P. Burke III,

HCFA Reports Clearance Officer, Division of

HCFA Enterprise Standards, Health Care

Financing Administration.

[FR Doc. 97–21650 Filed 8–14–97; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Initial

Review Group (IRG) meeting:

Name of IRG: Clinical Trials Review

Committee.

Date: October 26–29, 1997.

Time: 7:00 p.m.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, Maryland

20814.

Contact Person: Dr. Joyce A. Hunter, 6701

Rockledge Drive, Rm. 7192, MSC 7924,

Bethesda, Maryland 20892, (301) 435–0287.

Purpose/Agenda: To review and evaluate

grant applications.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: August 8, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–21624 Filed 8–14–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meeting:

Name of SEP: Jackson Heart Study

Feasibility Study (Telephone Conference

Call).

Date: September 3, 1997.

Time: 2:00 p.m.

Place: Two Rockledge Center, 6701

Rockledge Drive, Room 7214, Bethesda,

Maryland 20892.

Contact Person: C. James Scheirer, Ph.D.,

Two Rockledge Center, Room 7214, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0266.

Purpose/Agenda: To review and evaluate

contract proposals.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than

fifteen days prior to this meeting due to the

urgent need to meet timing limitations

imposed by the grant/contract review and

funding cycle.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: August 8, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–21625 Filed 8–14–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Dental Research;

Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Dental Research

Special Emphasis Panel (SEP) meeting:

Name of SEP: National Institute of Dental

Research Special Emphasis Panel—Review of

R01 (97–62).

Dates: September 4, 1997.

Time: 3:00 p.m.

Place: Natcher Building, Rm. 4AN–44F,

National Institutes of Health, Bethesda, MD

20892 (teleconference).

Contact Person: Dr. George Hausch, Chief,

Grants Review Section, 4500 Center Drive,

Natcher Building, Room 4AN–44F, Bethesda,

MD 20892, (301) 594–2372.

Purpose/Agenda: To evaluate and review

grant applications and/or contract proposals.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.121, Oral Diseases and

Disorders Research)

Dated: August 11, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–21616 Filed 8–14–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases;

Meeting of the National Diabetes and

Digestive and Kidney Diseases

Advisory Council and Its

Subcommittees

Pursuant to Pub. L. 92–463, notice is

hereby given of a meeting of the

National Diabetes and Digestive and

Kidney Diseases Advisory Council and

its subcommittees, National Institute of

Diabetes and Digestive and Kidney

Diseases, on September 17–18, 1997.

The meeting of the full Council will be

open to the public on September 17,

from 8:30 a.m. to 12:00 p.m. in

Conference Room 6, Building 31C,

National Institutes of Health, Bethesda,

Maryland, to discuss administrative

issues relating to Council business and